Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Irritable Bowel Syndrome

Free Subscription 26.01.2026 1 Am J Transl Res 1 Biopsychosoc Med 1 BMJ Open 1 Clin Rheumatol 1 Commun Biol 1 Emerg Infect Dis 1 Eur J Pharmacol 1 Front Cell Infect Microbiol 1 Front Nutr 1 Gut 1 Int Immunopharmacol 1 J Agric Food Chem 1 J Gastroenterol Hepatol 1 J Hum Nutr Diet 1 Lancet Gastroenterol Hepatol 1 Nat Rev Gastroenterol Hepatol 2 Neurogastroenterol Motil 1 PLoS One 1 Postgrad Med 1 United European Gastroenterol J 1 World J Gastroenterol 1 World J Psychiatry

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Transl Res

1. HONG J, Ji R, Wang P, Huang F, et al
   A set of downregulated pleiotropic genes are possible multi-omics biomarkers underlying the irritable bowel syndrome-non-alcoholic fatty liver disease comorbidity.
   Am J Transl Res. 2025;17:9494-9515.
   PubMed         Abstract available
   
   

   
   Biopsychosoc Med

2. SUGAYA N, Izawa S, Sasaki T
   Effects of irritable bowel syndrome and related cognitive-behavioral and occupational stress factors on the productivity and abdominal symptoms of Japanese workers: a longitudinal study.
   Biopsychosoc Med. 2026 Jan 19. doi: 10.1186/s13030-026-00349.
   PubMed        
   
   

   
   BMJ Open

3. LIU Y, Yan X, Yang J, Zhang D, et al
   Efficacy and safety of non-pharmacological therapies for irritable bowel syndrome with diarrhoea: protocol for systematic review and network meta-analysis.
   BMJ Open. 2026;16:e105579.
   PubMed         Abstract available
   
   

   
   Clin Rheumatol

4. PONTES-SILVA A
   Heterogeneity and patient stratification in fibromyalgia and irritable bowel syndrome treatment studies: systematic review discussion.
   Clin Rheumatol. 2026 Jan 17. doi: 10.1007/s10067-026-07953.
   PubMed        
   
   

   
   Commun Biol

5. CHATZOPOULOU MS, Vumma R, Prado S, Scharf MW, et al
   Development of a novel humanized gut-brain axis model as a tool toward personalized nutrition.
   Commun Biol. 2026;9:73.
   PubMed         Abstract available
   
   

   
   Emerg Infect Dis

6. MIKO S, Kache PA, Imada E, Freeland AL, et al
   Postinfectious Syndromes and Long-Term Sequelae after Giardia Infections.
   Emerg Infect Dis. 2025;31:45-52.
   PubMed         Abstract available
   
   

   
   Eur J Pharmacol

7. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
   Bombesin improves visceral hypersensitivity and colonic hyperpermeability via BB(1) receptor-dependent multi-pathway mechanisms in a rat model of irritable bowel syndrome.
   Eur J Pharmacol. 2026;1015:178566.
   PubMed         Abstract available
   
   

   
   Front Cell Infect Microbiol

8. ZHUANG Z, Lv B, Chen Y, Chen J, et al
   The effect of Massa Medicata Fermentata on the cytokine secretion of colonic mucosa and visceral sensitivity in rats with IBS-D.
   Front Cell Infect Microbiol. 2026;15:1616796.
   PubMed         Abstract available
   
   

   
   Front Nutr

9. BOGDANOWSKA-CHARKIEWICZ D, Malinowska U, Daniluk J
   An umbrella review of meta-analyses on the low-FODMAP diet in IBS.
   Front Nutr. 2026;12:1714281.
   PubMed         Abstract available
   
   

   
   Gut

10. DIAZ-MUNOZ C, Bozzarelli I, Lopera-Maya EA, Belbasis L, et al
    Genetic dissection of stool frequency implicates vitamin B1 metabolism and other actionable pathways in the modulation of gut motility.
    Gut. 2026 Jan 20:gutjnl-2025-337059. doi: 10.1136/gutjnl-2025-337059.
    PubMed         Abstract available
    
    

    
    Int Immunopharmacol

11. LYU D, Wang X, Zhang J, Fu S, et al
    Glucocorticoid signaling mitigates colitis-associated visceral hypersensitivity by suppressing 5-HT release in enterochromaffin cells via a GR-PI3K-SGK1 axis.
    Int Immunopharmacol. 2026;172:116207.
    PubMed         Abstract available
    
    

    
    J Agric Food Chem

12. JIN R, Zhou Z, Lou Y, Wang X, et al
    Peoniflorin Alleviates Corticotropin-Releasing Factor-Induced Irritable Bowel Syndrome by Improving the Intestinal Barrier Function through the Inhibition of the CRFR1/ROCK2/MLC Signaling Pathway.
    J Agric Food Chem. 2026 Jan 19. doi: 10.1021/acs.jafc.5c10339.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

13. MACK A, Halmos EP, Mogilevski T, Anderson EJ, et al
    A Critical Review of Persistent Gastrointestinal and Extraintestinal Symptoms in Quiescent Inflammatory Bowel Disease: Time for Greater Precision and Clarity.
    J Gastroenterol Hepatol. 2026 Jan 18. doi: 10.1111/jgh.70223.
    PubMed         Abstract available
    
    

    
    J Hum Nutr Diet

14. FARSI DN, Whelan K, Dimidi E
    Perceptions of the Role of Diet Among People With Constipation: Dietary Contributors and Relievers to Symptoms and Research Priorities.
    J Hum Nutr Diet. 2026;39:e70201.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

15. DAMIANOS JA, Wang XJ, Camilleri M
    Mechanisms and pathophysiology leading to development of small intestinal microbial dysbiosis.
    Lancet Gastroenterol Hepatol. 2026 Jan 14:S2468-1253(25)00295.
    PubMed         Abstract available
    
    

    
    Nat Rev Gastroenterol Hepatol

16. DIMIDI E, Whelan K, Scott SM
    Dietary guidelines for gastrointestinal disorders: key to optimizing practice but more work needed.
    Nat Rev Gastroenterol Hepatol. 2026 Jan 22. doi: 10.1038/s41575-025-01171.
    PubMed        
    
    

    
    Neurogastroenterol Motil

17. KRUEGER A, Waheed U, Santucci N
    Overlap of Structural Gastrointestinal Disorders in Children With Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2026;38:e70231.
    PubMed         Abstract available
    
    
18. MULAK A
    The Hidden Role of Dreams and Nightmares in Gastrointestinal Disorders: Exploring a Nocturnal Blind Spot in Sleep Research.
    Neurogastroenterol Motil. 2026;38:e70240.
    PubMed        
    
    

    
    PLoS One

19. ROHNER S, Schnepper R, Meienberg A, Bopp K, et al
    Protocol of the digital long COVID study: A single-center, registry-based, feasibility and clinical evaluation study to investigate a 12-week digital intervention program for people affected by post-COVID-19 condition.
    PLoS One. 2026;21:e0340385.
    PubMed         Abstract available
    
    

    
    Postgrad Med

20. GUO D, Song Y, Yuan L, Chu W, et al
    The gut-Joint axis: investigating functional gastrointestinal disorders as risk factors for prosthetic joint infections a retrospective case-control study.
    Postgrad Med. 2026 Jan 21:1-6. doi: 10.1080/00325481.2026.2619422.
    PubMed         Abstract available
    
    

    
    United European Gastroenterol J

21. SILVA H, Zheng T, Porter J, Barrett J, et al
    The Associations of Sucrase-Isomaltase Hypomorphic Variants With Long-Term Outcomes and Dietary Intake in an Australian Irritable Bowel Syndrome Population Educated on the FODMAP Diet: A Cross-Sectional and Retrospective Study.
    United European Gastroenterol J. 2026;14:e70173.
    PubMed         Abstract available
    
    

    
    World J Gastroenterol

22. KUMAR A, Sarangi Y, Kaw P
    Gene, genetics and genetic medicines in gastroenterology: Current status and its future.
    World J Gastroenterol. 2026;32:112496.
    PubMed         Abstract available
    
    

    
    World J Psychiatry

23. YEH ST, Li MY, Chen YC
    Mental and physical health outcomes among intimate partner violence survivors in Taiwan: A nationwide registry-based case control study.
    World J Psychiatry. 2026;16:112745.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum